NSAIDs, gastrointestinal toxicity and inflammatory bowel disease
Authors:
- Gonzalo Hijos-MalladaGHGonzalo Hijos-Mallada
- Carlos SostresCSCarlos Sostres
- Fernando GomollónFGFernando Gomollón
- 9 February 2022
- journal article
- Published by Elsevier in Gastroenterología y Hepatología (English Edition)
- Vol. 45 (3) , 215-222
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 2016
- Inverse Expression of Prostaglandin E2-Related Enzymes Highlights Differences Between Diverticulitis and Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2015
- Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel diseaseCochrane Database of Systematic Reviews, 2014
- First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory CoursesAmerican Journal of Gastroenterology, 2014
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageArthritis Research & Therapy, 2013
- Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patientsGut, 2013
- Drug-Induced Inflammatory Bowel Disease and IBD-Like ConditionsInflammatory Bowel Diseases, 2013
- Aspirin in the aetiology of Crohn’s disease and ulcerative colitis: a European prospective cohort studyAlimentary Pharmacology & Therapeutics, 2011
- Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot StudyClinical Gastroenterology and Hepatology, 2006